Test Bank for Pharmacotherapeutics For Advanced Practice Nurse Prescribers 4th Edition, Kindle Edition by Teri Moser Woo ISBN: 9780803638273| Complete Guide A+

TESTBANK
b

, Pharmacotherapeutics forAdvancedPracticeNurse Prescribers, 4th b b b b b b




edition Woo Robinson Test Bank b b b b b




Chapter1. The Role of the Nurse Practitioner as PrescriberMultiple Choice
b b b b b b b b b b




Identify the choice that best completes thestatement or answers the question.
b b b b b b b b b b b




1. Nurse practitioner prescriptive authorityis regulated by:
b b b b b b b




1. The National Council of State Boards of Nursing
b b b b b b b




2. The U.S. Drug Enforcement Administration
b b b b




3. The State Board of Nursing for each state
b b b b b b b




4. The State Board of Pharmacy b b b b




2. Thebenefits to the patient of having an Advanced Practice Registered Nurse (APRN)prescriber
b b b b b b b b b b b b b b




include:
b




1. Nurses know more about Pharmacologythan other prescribers because theytakeit
b b b b b b b b b b b




both in their basic nursing program and in their APRN program.
b b b b b b b b b b b




2. Nurses care for the patient from a holistic approach and include the patient in
b b b b b b b b b b b b b




decision making regarding their care.
b b b b b




3. APRNs are less likelyto prescribe narcotics and other controlled substances.
b b b b b b b b b b




4. APRNs areable to prescribe independently in all states, whereas a physician’s
b b b b b b b b b b b




assistant needs to have a physician supervising their practice.
b b b b b b b b b




3. Clinical judgment in prescribing includes:
b b b b b




1. Factoring in the cost to the patient of the medication prescribed b b b b b b b b b b




2. Always prescribing the newest medication available for the disease process
b b b b b b b b b




3. Handing out drug samples to poor patients b b b b b b




4. Prescribingall generic medications to cut costs b b b b b b




4. Criteria for choosing an effective drug for a disorder include:
b b b b b b b b b b




1. Asking the patient what drug theythink would work best for them
b b b b b b b b b b b




2. Consultingnationallyrecognized guidelines for disease management b b b b b b




3. Prescribingmedications that are available as samples before writing a prescription b b b b b b b b b b




4. Following U.S. Drug Enforcement Administration guidelines for prescribing b b b b b b b




5. Nurse practitioner practice may thriveunder health-care reform because of:
b b b b b b b b b b




1. The demonstrated ability of nursepractitioners to control costs and improvepatient
b b b b b b b b b b b




outcomes b




2. Thefact that nurse practitioners will be able to practice independently
b b b b b b b b b b




3. The fact that nurse practitioners will have full reimbursement under health-
b b b b b b b b b b




care reform b b




4. The ability to shift accountability for Medicaid to the state level
b b b b b b b b b b

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
b b b b b b




edition Woo Robinson Test Bank b b b b b




Chapter 1. The Role of the Nurse Practitioner as Prescriber
b b b b b b b b b




Answer Section
b b




MULTIPLE CHOICE b




1. ANS: b b 3 PTS: b 1
2. ANS: b b 2 PTS: b 1
3. ANS: b b 1 PTS: b 1
4. ANS: b b 2 PTS: b 1
5. ANS: b b 1 PTS: b 1

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th b b b b b b




edition Woo Robinson Test Bank b b b b b




Chapter2. Review of the Basic Principles of Pharmacology
b b b b b b b b




Multiple Choice
b b




Identify the choice that best completes the statement or answers the question.
b b b b b b b b b b b




1. A patient’s nutritional intake and laboratoryresults reflect hypoalbuminemia. This is critical to
b b b b b b b b b b b b b




prescribing because:
b b




1. Distribution of drugs to target tissue maybe affected. b b b b b b b b




2. The solubilityof the drug will not match the site of absorption.
b b b b b b b b b b b




3. There will be less free drug available to generate an effect.
b b b b b b b b b b




4. Drugs bound to albumin are readily excreted by the kidneys.
b b b b b b b b b




2. Drugs that have a significant first-pass effect:
b b b b b b b




1. Must be given by the enteral (oral) route only b b b b b b b b




2. Bypass the hepatic circulation b b b




3. Are rapidlymetabolized by the liver and may have little if any desired action
b b b b b b b b b b b b b




4. Are converted by the liver to more active and fat-soluble forms
b b b b b b b b b b




3. The route of excretion of a volatile drug will likely be the:
b b b b b b b b b b b b b




1. Kidneys
2. Lungs
3. Bileand feces b b




4. Skin

4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly(IM) to create astorage
b b b b b b b b b b b




reservoir of the drug. Storage reservoirs:
b b b b b b




1. Assurethat the drug will reach its intended target tissue b b b b b b b b b




2. Are the reason for giving loading doses
b b b b b b




3. Increase the length of time a drug is available and active b b b b b b b b b b




4. Are most common in collagen tissues
b b b b b




5. The NP chooses to give cephalexin every8 hours based on knowledge of the drug’s:
b b b b b b b b b b b b b b b




1. Propensityto go to the target receptor b b b b b b




2. Biological half-life b




3. Pharmacodynamics
4. Safety and side effects b b b




6. Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the
b b b b b b b b b b b b b b b b b b




prescription. This is considered a loading dose. A loading dose:
b b b b b b b b b b




1. Rapidlyachieves drug levels in the therapeutic range b b b b b b b




2. Requires four- to five-half-lives to attain b b b b b




3. Is influenced byrenal function
b b b b




4. Is directly related to the drug circulating to the target tissues
b b b b b b b b b b




7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic effect is the:
b b b b b b b b b b b b b b b b b b b b




1. Minimum adverse effect level b b b




2. Peak of action b b